Volitionrx (VNRX) Long-Term Deferred Tax (2021 - 2025)

Volitionrx's Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $49.8 million for Q4 2025.

• Quarterly Long-Term Deferred Tax rose 18.85% year-over-year to $49.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.8 million (up 18.85% YoY) and the FY2025 annual result came in at $49.8 million, up 18.85% from the prior year.
• Long-Term Deferred Tax was $49.8 million for Q4 2025 at Volitionrx, up from $41.9 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $49.8 million in Q4 2025 and bottomed at $25.3 million in Q4 2021.
• A 4-year average of $37.0 million and a median of $36.4 million in 2022 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax climbed 21.95% — and 2025, when it gained 18.85%.
• Volitionrx's Long-Term Deferred Tax stood at $25.3 million in 2021, then increased by 21.95% to $30.9 million in 2022, then jumped by 35.83% to $41.9 million in 2024, then increased by 18.85% to $49.8 million in 2025.
• Business Quant data shows VNRX's Long-Term Deferred Tax at $49.8 million in Q4 2025, $41.9 million in Q4 2024, and $30.9 million in Q4 2022.